Free Trial

De Lisle Partners LLP Purchases 24,321 Shares of The Pennant Group, Inc. (NASDAQ:PNTG)

The Pennant Group logo with Medical background

De Lisle Partners LLP boosted its holdings in shares of The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 7.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 343,340 shares of the company's stock after acquiring an additional 24,321 shares during the period. The Pennant Group comprises 2.0% of De Lisle Partners LLP's portfolio, making the stock its 10th largest holding. De Lisle Partners LLP owned approximately 1.00% of The Pennant Group worth $12,254,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in PNTG. State Board of Administration of Florida Retirement System acquired a new stake in The Pennant Group during the 1st quarter valued at $279,000. Vanguard Group Inc. grew its holdings in The Pennant Group by 4.3% during the 1st quarter. Vanguard Group Inc. now owns 1,859,679 shares of the company's stock valued at $36,505,000 after buying an additional 77,052 shares during the last quarter. Boston Partners grew its holdings in The Pennant Group by 15.2% during the 1st quarter. Boston Partners now owns 115,682 shares of the company's stock valued at $2,273,000 after buying an additional 15,291 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in The Pennant Group by 10.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 130,195 shares of the company's stock valued at $3,019,000 after buying an additional 12,141 shares during the last quarter. Finally, Bailard Inc. acquired a new stake in The Pennant Group during the 2nd quarter valued at $253,000. Institutional investors and hedge funds own 85.88% of the company's stock.

The Pennant Group Trading Down 1.0 %

Shares of PNTG stock traded down $0.32 during mid-day trading on Thursday, hitting $31.39. 213,357 shares of the company's stock were exchanged, compared to its average volume of 201,469. The Pennant Group, Inc. has a fifty-two week low of $13.24 and a fifty-two week high of $37.13. The stock has a 50-day simple moving average of $33.34 and a two-hundred day simple moving average of $29.46. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.58. The stock has a market cap of $1.08 billion, a price-to-earnings ratio of 46.16, a PEG ratio of 3.12 and a beta of 2.02.

Analysts Set New Price Targets

A number of brokerages have commented on PNTG. Royal Bank of Canada increased their target price on The Pennant Group from $26.00 to $38.00 and gave the company an "outperform" rating in a report on Wednesday, October 23rd. Oppenheimer increased their target price on The Pennant Group from $34.00 to $37.00 and gave the company an "outperform" rating in a report on Friday, November 8th. Truist Financial increased their target price on The Pennant Group from $34.00 to $38.00 and gave the company a "hold" rating in a report on Monday, October 7th. Finally, Stephens restated an "overweight" rating and set a $40.00 price objective on shares of The Pennant Group in a report on Wednesday, October 9th.

View Our Latest Stock Analysis on PNTG

The Pennant Group Company Profile

(Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Featured Stories

Institutional Ownership by Quarter for The Pennant Group (NASDAQ:PNTG)

Should you invest $1,000 in The Pennant Group right now?

Before you consider The Pennant Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.

While The Pennant Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Former Trump Advisor: Expect REITs to Soar Under Trump’s Next Presidency
Super Micro’s Rebound: Can SMCI Stock Rally Another 100%?
Why Meta Is Still a Top Stock Pick for 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines